Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.

[1]  M. Vieites,et al.  ESR, electrochemical and reactivity studies of antitrypanosomal palladium thiosemicarbazone complexes. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  B. Garat,et al.  Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. , 2008, Journal of inorganic biochemistry.

[3]  M. Kurup,et al.  Synthesis, spectral and EPR studies of oxovanadium(IV) complexes incorporating tridentate ONO donor hydrazone ligands: Structural study of one oxovanadium(V) complex , 2008 .

[4]  A. Gómez-Barrio,et al.  Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase , 2008, JBIC Journal of Biological Inorganic Chemistry.

[5]  Manfred Rudolph,et al.  Structural characterization and electrochemical behavior of oxovanadium(V) complexes with N-salicylidene hydrazides , 2007 .

[6]  M. Drew,et al.  Synthesis, structure, solution chemistry and the electronic effect of para substituents on the vanadium center in a family of mixed-ligand [VVO(ONO)(ON)] complexes , 2007 .

[7]  A. Sierraalta,et al.  Synthesis and characterization of [Au(dppz)2]Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana. , 2007, Journal of inorganic biochemistry.

[8]  Martín Ciganda,et al.  DNA conformational changes and cleavage by ruthenium(II) nitrofurylsemicarbazone complexes. , 2007, Journal of Inorganic Biochemistry.

[9]  A. Denicola,et al.  Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents. , 2006, European journal of medicinal chemistry.

[10]  M. H. Torre,et al.  Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium. , 2006, Bioorganic & medicinal chemistry.

[11]  L. Savioli,et al.  Reconsidering the underestimated burden caused by neglected tropical diseases. , 2006, Trends in parasitology.

[12]  R. Krauth-Siegel,et al.  Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. , 2006, Journal of medicinal chemistry.

[13]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.

[14]  Michael P Barrett,et al.  Chemotherapy of trypanosomiases and leishmaniasis. , 2005, Trends in parasitology.

[15]  R. Morphy,et al.  Designed multiple ligands. An emerging drug discovery paradigm. , 2005, Journal of medicinal chemistry.

[16]  M. Ceaser.  Battling with Chagas disease in South America , 2005 .

[17]  E. Castellano,et al.  Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)]. , 2005, Journal of inorganic biochemistry.

[18]  Martin Ebel,et al.  Synthesis, characterisation and catalytic potential of hydrazonato-vanadium(V) model complexes with [VO]3+ and [VO2]+ cores. , 2005, Dalton transactions.

[19]  R. Schirmer,et al.  Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. , 2005, Angewandte Chemie.

[20]  Thomas J. Meyer,et al.  Comprehensive Coordination Chemistry II , 2004 .

[21]  A. Anzellotti,et al.  Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents. , 2004, European journal of medicinal chemistry.

[22]  D. Gambino,et al.  The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. , 2003, Mini reviews in medicinal chemistry.

[23]  Y. Adachi,et al.  New Vanadium(V) Complexes with Salicylaldehyde Semicarbazone Derivatives: Synthesis, Characterization, and in vitro Insulin‐Mimetic Activity − Crystal Structure of [VvO2(salicylaldehyde semicarbazone)] , 2004 .

[24]  A. Anzellotti,et al.  Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis. , 2004, Mini reviews in medicinal chemistry.

[25]  M. Fernandez-Mestre,et al.  Synthesis, characterization, DNA binding study and biological activity against Leishmania mexicana of [Cu(dppz)2]BF4. , 2003, Journal of inorganic biochemistry.

[26]  S. Lippard,et al.  New metal complexes as potential therapeutics. , 2003, Current opinion in chemical biology.

[27]  J. Urbina.  New chemotherapeutic approaches for the treatment of Chagas disease (American Trypanosomiasis) , 2003 .

[28]  J. Ellena,et al.  Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease , 2003 .

[29]  N. Farrell,et al.  Metal Complexes as Drugs and Chemotherapeutic Agents , 2003 .

[30]  V. Félix,et al.  Molecular modelling studies of N-salicylideneamino acidato complexes of oxovanadium(IV). Molecular and crystal structure of a new dinuclear LOVIV–O–VVOL mixed valence complex , 2002 .

[31]  H. Cerecetto,et al.  Chemotherapy of Chagas' disease: status and new developments. , 2002, Current topics in medicinal chemistry.

[32]  D. Rehder,et al.  Biomimetic oxo-, dioxo- and oxo-peroxo-hydrazonato-vanadium(IV/V) complexes , 2002 .

[33]  V. Pecoraro,et al.  Paramagnetic spectroscopy of vanadyl complexes and its applications to biological systems , 2002 .

[34]  D. Rehder,et al.  Dioxo- and Oxovanadium(V) Complexes of Biomimetic Hydrazone ONO Donor Ligands: Synthesis, Characterisation, and Reactivity , 2001 .

[35]  R. Gillard,et al.  PREPARATION AND CHARACTERISATION OF NEW OXOVANADIUM(IV) SCHIFF BASE COMPLEXES DERIVED FROM AMINO ACIDS AND AROMATIC O-HYDROXYALDEHYDES , 1999 .

[36]  A. Rockenbauer,et al.  Automatic computer simulations of ESR spectra , 1996 .

[37]  J. Lown,,et al.  Studies on the ability of minor groove binders to induce supercoiling in DNA , 1993, FEBS letters.

[38]  D. Lin-Vien.  The Handbook of Infrared and Raman Characteristic Frequencies of Organic Molecules , 1991 .

[39]  Frederick M. Ausubel,et al.  Short protocols in molecular biology : a compendium of methods from Current protocols in molecular biology , 1989 .

[40]  Colin Eaborn,et al.  Comprehensive Coordination Chemistry , 1988 .

[41]  S. Colonna,et al.  Synthesis, characterization and catalytic oxidations of oxovanadium(IV), oxotitanium(IV) and dioxomolybdenum(VI) complexes with chiral imines of L-amino acids , 1988 .

[42]  K. Kinnamon,et al.  Activity of Antitumor Drugs Against African Trypanosomes , 1979, Antimicrobial Agents and Chemotherapy.

[43]  Lawrence J. Berliner,et al.  Biological Magnetic Resonance , 1982, Biological Magnetic Resonance.

[44]  W. Geary.  The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .

[45]  L. A. Summers,et al.  Derivatives of 1,10-Phenanthroline-5,6-quinone , 1970 .

[46]  K. Wüthrich.  Elektronenspinresonanz‐Untersuchungen von VO2+‐Komplexverbindungen in wässeriger Lösung II , 1965 .